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Malnutrition is a significant factor in predicting cancer patients’ quality of life (QoL). We systematically reviewed the
literature on the role of nutritional status in predicting QoL in cancer. We searched MEDLINE database using the
terms “nutritional status” in combination with “quality of life” together with “cancer”. Human studies published in
English, having nutritional status as one of the predictor variables, and QoL as one of the outcome measures were
included. Of the 26 included studies, 6 investigated head and neck cancer, 8 gastrointestinal, 1 lung, 1 gynecologic
and 10 heterogeneous cancers. 24 studies concluded that better nutritional status was associated with better QoL, 1
study showed that better nutritional status was associated with better QoL only in high-risk patients, while 1 study
concluded that there was no association between nutritional status and QoL. Nutritional status is a strong predictor
of QoL in cancer patients. We recommend that more providers implement the American Society of Parenteral and
Enteral Nutrition (ASPEN) guidelines for oncology patients, which includes nutritional screening, nutritional
assessment and intervention as appropriate. Correcting malnutrition may improve QoL in cancer patients, an
important outcome of interest to cancer patients, their caregivers, and families.
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Disease-related malnutrition occurs frequently in
patients with cancer and is a major cause of morbidity
and mortality.[1] The incidence of malnutrition in cancer
patients ranges between 40 and 80% [2] while the preva-
lence ranges from 50% to 80%[3] depending on tumor
type, tumor location, stage of disease, treatment received
and the type of nutritional assessment method used.[4]
Decreased dietary intake, cancer cachexia (characterized
mainly by weight loss and muscle wasting), and nutrition
impact symptoms may all contribute to cancer-related
malnutrition.[3] Additionally, the treatment modalities
involving combinations of chemotherapeutic, radiothera-
peutic and surgical regimens are known to produce vari-
ous acute and chronic symptoms that limit eating and,
thereby, exert a profound impact on nutritional status.
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reproduction in any medium, provided the orAs a result, it is important to assess every cancer
patient’s nutritional status using one or more methodolo-
gies that are developed for this purpose. Anthropometric
measurements [such as weight change, arm muscle cir-
cumference (AMC), triceps skin-fold thickness (TSF)]
and biochemical parameters (such as serum albumin)[6]
are often used. Other instruments, such as Subjective
Global Assessment (SGA)[7] and Patient-Generated Sub-
jective Global Assessment (PG-SGA), which has been
adapted from the SGA and designed specifically for
patients with cancer[3,8] are also used. Still other tools
have been recommended by the European Society for
Clinical Nutrition and Metabolism, including Nutritional
Risk Screening (NRS-2002), which has demonstrated
high sensitivity and specificity at hospital admission; the
Malnutrition Universal Screening Tool (MUST), which
was devised for people who live in a community setting
and relates their nutrition to their functions; and the
Mini Nutritional Assessment (MNA), which was
designed specifically for elderly people.[9] Tools such as
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ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Lis et al. Nutrition Journal 2012, 11:27 Page 2 of 18
http://www.biomedcentral.com//11/1/27Analysis (BIA) and hand grip strength measured by
dynamometry are also used as markers of nutritional sta-
tus.[10] The utility of these nutritional screening tools
has been evaluated by their ability to predict relevant
clinical outcomes such as complications, treatment re-
sponse, survival and quality of life (QoL).
Quality of life for cancer patients is a subjective multi-
dimensional construct that represents the patient’s func-
tional status, psychosocial well-being, health perceptions
and disease/treatment-related symptoms.[7] In all, QoL
reflects health status in cancer patients, which, in turn, is
largely influenced by nutritional factors.[9] Cancer and
treatment-induced changes in metabolism can lead to
alterations in physiological and psychological functions,
which, in turn, can reduce a patient’s QoL by negatively
influencing nutritional status.[11]
Measuring a patient’s QoL is contingent upon clinical
goals and may require a variety of different instruments.
Among them are the European Organization for Re-
search and Treatment of Cancer quality-of-life core
questionnaires (EORTC QLQ-C30), the Functional As-
sessment of Cancer Therapy-General (FACT-G), Func-
tional Living Index cancer questionnaire (FLIC), Spitzer
Quality of Life Index (QLI), Rotterdam Symptom Check
List (RSCL), the Medical Outcome Study 36-item short
form (MOS SF-36), EuroQol (EQ-5D)[9], the Cancer Re-
habilitation Evaluation System (CARES)[12] and the
Symptom Distress Scale.[13]
Researchers have studied the correlation between nutri-
tional status and QoL for some time and there are a num-
ber of articles in the literature that provide data on this
association in cancer patients. Because these studies differ
from each other with respect to patient population, study
design, sample size and type of nutritional and QoL assess-
ment used, it can be difficult to interpret and synthesize
common findings. Our goal was to systematically review
the available literature, summarize the vast amount of in-
formation on the topic of nutrition and QoL in cancer
patients, and provide direction for future research.
Methods
Data sources
We attempted to plan, conduct, and report this meta-
analysis in accordance with the PRISMA statement.
[14,15] MEDLINE database was used to identify all arti-
cles investigating the relationship between nutritional
status and QoL in cancer published between January 01,
1990 and June 30, 2011. We also searched the bibliog-
raphies of selected papers to identify relevant articles we
might have missed during the primary MEDLINE search.
Study eligibility criteria
To be included in this review, an article must have: been
published in English, reported on data collected inhumans with cancer, had malnutrition/nutritional status/
assessment/screening as one of the predictor variables,
had QoL as one of the outcome measures (primary or
secondary), and had any of the following study designs
(case–control, cohort, cross-sectional, prospective, retro-
spective, case series, longitudinal, clinical trial, meta-ana-
lysis). There were no restrictions based on age, ethnicity,
type or stage of cancer.
Search
We searched the MEDLINE database using the terms
“nutritional status” or “nutritional assessment” or “nutri-
tional screening” or “malnutrition” in combination with
the following terms: “quality of life”, and “health-related
quality of life” together with “cancer” or “oncology”.
Study selection
Study selection was based on an initial screen of identi-
fied abstracts or titles and a second screen of full-text
articles. Articles to be included in this review were
screened for eligibility by two reviewers working inde-
pendently. Disagreements between reviewers were
resolved by consensus.
Data collection process
One review author extracted the required data elements
from included articles and the second author verified
the extracted data. Disagreements were resolved by dis-
cussion between the two review authors. Tables 1, 2, 3,
4, 5 reflect the template for data collection.
Data items
Instead of providing aggregate quality scores, we assessed
the quality of individual studies by reporting the key
components of study designs. The following information
was extracted for each article: first author, year of publi-
cation, study place, data collection period, study design,
sample size, nutritional assessment method, QoL assess-
ment method, nutritional groups being compared, key
results and conclusions.
Synthesis of results
The authors summarized all studies reviewed in this
paper in separate tables based on the cancer type. Within
each table, studies are arranged chronologically by the




The MEDLINE search identified a total of 676 articles
based on different combinations of search terms
described above. The authors reviewed the titles and
abstracts of these 676 articles to identify the relevant


































EORTC QLQ C-30 Weight loss>=10% in





(p = .007)and fatigue
(p = .034) were significantly





score lower on quality







61 Head & Neck
CancerOropharynx:
n = 21; Oral cavity:
n = 19Nasopharynx:
n = 13; Larynx: n = 5;
Maxillary sinus:
n = 2Submandibular




EORTC QLQ C-30 Unintended weight loss
–Non-malnourished:
involuntary loss of< 5% of
body weight in the last
3 months (n = 36) &
Malnourished: ≥ 5% loss
of body weight in the last
3 months (n = 25)
1. Unintended weight
loss –Multivariate:
Malnutrition (UWL) and Hb
level independently
influenced physical
(p = 0.002; p = 0.005), role
(p = 0.004; p = 0.001), and
social functions (p = 0.024;
p = 0.009).2. PG-SGA score



























UW-QOL BMI change was taken as a
continuous variable
The 12-month BMI drop
was inversely correlated
with current HRQOL,
signifying that weight loss
correlated with a poorer
subsequent HRQOL score






drop in BMI and the
current HR-QOL may



















cavity: n = 23;
Oropharynx: n = 18;













≥ 10% &< 10% weight loss
at baseline
1. At baseline: Patients
≥10% weight loss in
6 months before baseline






saliva and coughing were
worse in the≥ 10% weight
loss group.2. At the end
of treatment: Patients
who had lost≥ 10% weight
had lower role and social























Table 1 Nutritional status and quality of life in head and neck cancer (Continued)
functioning. Scores
significantly differed for
global (p = 0.01), fatigue
(p = 0.03), pain (p = 0.04),
senses problems (0.05),
sticky saliva (p = 0.01),
coughing (p = 0.02) and
feeling ill (p = 0.01) during
treatment.3. Six months
after treatment:
Patients≥ 10% weight loss
















n = 15; Laryngeal:
n = 12; Oral: n = 12;












≥ 10% weight loss (n = 20)
&< 10% weight loss
(n = 29)
(A) At different time-
points: Patients who
lost≥ 10% in weight during
6 months had worse HRQL
at diagnosis than did
patients who lost less at all
time-points.(B) HADS: At
diagnosis, 37% of
the≥ 10% weight loss
group had Possible/
probable depression versus
17% of the <10% weight-
loss group. This tendency
remained after 3 months
(38% vs 20%), at 1-year
follow-up (44% vs 5%), and
after 3 years (27% vs 15%).
Patients with head and
neck cancer who are at
risk of severe weight
loss developing during
treatment may be
















n = 4Other: n = 3
1. Weight loss2.
Anthropo-metry:(a)









1. Weight loss:> 5%
&≤ 5% of the body
weight2. Anthropometry:
Based on Swedish
reference values3. WI: <
0.80 &≥ 0.804. BMI: ≥ 20
&< 205. S-alb: < 33 g/L
&≥ 33 g/LGroups for
analysis(1) malnutrition (n
=25) versus normal (n = 22),
(2) weight loss (n = 20)
versus no weight loss
(n = 24),(3) negative energy






patients scored worse for
12 of the 16 functions/
symptoms. The greatest
differences between the
two groups were found for
Physical Function, global
QoL, and Role Function,
NS.2. Weight loss versus
no weight loss: Patients
with weight loss scored
worse for 11 of 16
functions.(a) Swallowing
difficultiesMean score = 52
& 18 for those with weight

























Table 1 Nutritional status and quality of life in head and neck cancer (Continued)
foodMean score = 62 & 29
for those with weight loss




groups of patients with
negative energy balance
scored better than the
group of patients with
positive energy balance for





























































intake<70 g and>=70 g
The relative risk (95%
confidence interval) was 1.16
(1.02–1.32) for low levelof
daily calorie intake versus
normal level of daily calorie
intake.
Low level of daily calorie
intake may be the risk factor
of poor performance status of





















EORTC QLQ-C30 Calorie intake, BMI and
albumin used as continuous
variables
After age, sex, and stage of
the disease were adjusted,
patients with high daily
intakes of calories and
protein, as well as high level
of albumin, had a significantly
better quality of life.
Nutrition status 1 year after
being dischargedfrom
hospitals may be associated














48 with a recent (<







EORTC-QLQ C30 1. Weight Loss: > 10% in
the previous six months
or> 5% in the last month
&< 10% in the previous six
months or< 5% in the last
month.2. PG-SGAWell-
nourished, mild malnutrition
(MN) & severe MN.3. Hand
Grip Dynamometry: Below
85% & above 85%
Malnutrition identified
through PG-SGA, percentage
of weight loss at 1 month,
FFMI or dynamometry was
positively associated to a
worse QoL with the worst
performance in all dimensions
of QoL being attributed to
those patients identified as
malnourished by PG-SGA.
PG-SGA was correlated with














233 with esophageal or
cardia
cancerAdenocarcinoma
cardia: n = 102;
esophageal
adenocarcinoma: n = 82;
Oesophageal squamous














I: Stable or increased, Group
II: decrease of 1–4%,Group
III: 5–9% decrease, Group IV:
10–14% decrease,Group V:
15–19% decrease, Group VI:
≥ 20% decrease
Patients with a BMI decrease
of at least 20 per cent
experienced more appetite
loss (mean score difference
26; P = 0002), eating
difficulties (mean score
difference 18; P< 0002) and
odynophagia (mean score
difference 12; P = 0044) than
patients without
postoperative weight loss,
whereas scores for dysphagia
and gastro-oesophageal reflux
were similar between these
groups.
Malnutrition is a considerable
problem after
oesophagectomy, and is














EORTC-QLQ C30 Well nourished: SGA-A
(n = 34) &Malnourished:
(SGA-B&C)(n = 24)All others
SGA: Well-nourished patients
had significantly better QoL
scores in the global, physical,
Malnutrition is associated





















were used as continuous
variables.







correlated with the physical
and role function scales and
fatigue and appetite loss
symptom scales.
























Good, modest and bad
quality of life
For both males and females,
the daily nutrition intake
among three groups, except
vitamin C, were statistically
different, which suggested
that the patients who had a
better nutritional status had a
higher quality of life.
The nutritional status of the
operated patients with
stomach cancer may impact
their QoL. Exercise for
rehabilitation can whet the
appetite of the patients and
recover their body function,












n = 179; Gastric: n = 433;
Pancreatic: n = 162;
Colorectal: n = 781;
Weight loss at
presentation
EORTC-QLQ-C30 With weight loss & no weight
loss
Patients with weight loss at
presentation had a mean
quality of life score which was
less than patients with no
weight loss, especially in
patients with gastric
(P< 0.008), pancreatic and
colorectal cancers (P< 0.0001)
and also when all sites were
combined. (P< 0.0001).
Patients with weight loss had




NA Prospective 119 gastrointestinal
cancerColorectal: n = 43;
Esophageal: n = 27;
Gastric: n = 38;
Pancreatic: n = 11
Weight loss**








Weight-stable (< 5% weight
loss) (n = 22) & Weight-losing
(> 5% weight loss) (n = 97)
1. EuroQol EQ-5D –Median
(range) = 0.85 (0.03-1.00) &
0.52 (−0.26-1.00) respectively
for weight-stable and weight-
losing groups, p< 0.001.2.
EORTC QLQ-C30 –The
results in most subscales of
the EORTC QLQ-C30
questionnaire were poorer in
the weight-losing group
(p< 0.01).
Weight loss and reduction of
appetite are important related
factors in lowering the quality







































NA Prospective 106 inoperable NSCLC
(stage III and IV)By
stage –Stage III:
n = 78Stage IV: n = 28
Weight loss** defined
as loss of more than 5%





weight loss) (n = 61) &
Weight-losing (> 5%
weight loss) (n = 45)
(a) Global QoL:Median (range) = 50 (0–100) & 33.3
(0–66.7) respectively for weight-stable & weight-
losing groups, p = 0.027.(b) Symptom scores:
Fatigue (P< 0.05) and pain (P< 0.01) were
significantly greater in the weight-losing group.i.
Fatigue: –Median (range) = 55.6 (0–100) & 66.7 (0–
100) respectively for weight-stable & weight-losing
groups, p = 0.044.ii. Pain: –Median (range) = 16.7 (0–
100) & 41.7 (0–100) respectively for weight-stable &


























































cancer: n = 45Benign
adnexal mass: n = 79
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http://www.biomedcentral.com//11/1/27articles based on the selection criteria described above.
Of the 676 original articles, the authors excluded 641
from this review because it was clear from the abstracts
that these papers did not meet the selection criteria. The
authors then obtained the full texts of the remaining 35
articles for review. Thirteen of the 35 articles failed to
meet the selection criteria and were excluded. The
authors then identified 4 additional articles from the
bibliographies of the selected 35 articles. Twenty-six arti-
cles were then included in the final review for this manu-
script. Figure 1 is a flow chart that describes this process
and its results.
Characteristics of included studies
All 26 articles included in this review were published in
English. The authors extracted the following data from
each included study: first author, year of publication,
study place, data collection period, study design, sample
size, nutritional assessment method, QoL assessment
method, nutritional groups being compared, key results
and conclusions.
Synthesis of results
Nutritional status and QoL in head and neck cancer
Table 1 describes studies exploring the relationship be-
tween nutritional status and QoL in patients with head
and neck cancer. Of the six studies, one was a retro-
spective consecutive case series[17], one was cross-sec-
tional[16] and four were prospective.[8,12,18,19] The
sample size in these studies ranged from 36[17] to a
maximum of 115[16] patients. The study populations
included locally advanced head and neck cancers, can-
cers of the oropharynx, oral cavity/nasopharynx, larynx,
maxillary sinuses/submandibular glands/pharyngeal and
hyopharyngeal regions. Weight loss was the most com-
monly used nutritional assessment method, which was
measured exclusively[18,19] or in combination with PG-
SGA[8] or together with anthropometric measurements[AMC and TSF], weight index (WI), body mass index
(BMI) and serum albumin (S-alb) level.[12] One of the
studies assessed nutritional status in terms of the drop in
BMI over a period of 12 months.[17] The studies also
employed various tools for assessment of QoL, which
included the EORTC-QLQ-C30, either singly [8] or to-
gether with a head and neck specific module EORTC-
QLQ-H&N35 – either alone[18] or in combination with
Hospital Anxiety and Depression Scale (HADS).[19] One
of the studies used the EORTC-QLQ-C30 together with
a head and neck module developed in Norway[12] while
another used the University of Washington Head and
Neck Disease-Specific Measure (UW-QOL).[17] Weight
loss was the principal criterion used to categorize the
study population into comparison groups. Two studies
categorized the patients based on their weight loss per-
centage (≥ 10% and< 10%)[18,19] while another study
categorized its sample population based on unintentional
weight loss of< 5% (non-malnourished) and ≥ 5% (mal-
nourished) respectively.[8] Still another study used the
change in BMI as a continuous variable[17], and another
grouped its study population based on malnourished vs.
normal nutrition, weight loss vs. no weight loss and
negative vs. positive energy balance.[12] All six studies
concluded that better nutritional status was positively
associated with better QoL in the study patients. Inter-
estingly, 3 studies[12,17,18] found an association be-
tween weight loss & swallowing function. Swallowing
difficulty can cause weight loss, and as people lose
weight, swallowing function can be further compromised
due to muscle function loss and contribute to decline in
QoL.
Nutritional status and QoL in gastrointestinal cancer
Table 2 describes studies that explored the association
between nutritional status and QoL in patients with
gastrointestinal cancer. Of the eight studies included in
this table, three were retrospective[24-26], two were
























Head and Neck: 30; Urinary









Most QoL functional scales
were significantly reduced
in malnutrition and the
majority of symptom scales
were higher in the
malnourished patients.




19.4%, p< 0.001) next to
age and gender, which
were the strongest
predictors.
Malnutrition is a disease
independent risk factor for
reduced muscle strength












399 with solid or
hematologic tumor
diseaseGastrointestinal:
n = 149; Head and neck or
lung: n = 71; Urogenital:
n = 23; Gynecologic: n = 35;
Neuroendocrine, adrenal,
thyroid: n = 30; Others:
n = 20; Hematologic
disease: n = 71




1. SGA –SGA-A: Well
nourished (n = 167)SGA-B:
Moderately malnourished
(n = 132) & SGA-C: Severely
malnourished (n = 100).2.
BIA –Below fifthpercentile
(n = 191) & above fifth
percentile (n = 208) of the
phase angle
Univariate:All function




impaired in patients with a
phase angle below the fifth
reference percentile, and









function as were sex, age,
and SGA in a GLM
regression model and an
independent predictor for
EORTC global function




angle is an independent
predictor for impaired
functional and nutritional
status than are malnutrition








Prospective 61Colon: n = 8;Rectum:
n = 8;Breast: n = 11;Lung:
n = 7;Stomach: n = 4;
Prostate: n = 3; Kidney:
n = 3;Nasopharynx: n = 3;
Leukemia: n = 3; Liver:






correlated to total quality
of life score (p = 0.000). PG-
SGA score alone was able
to explain 38% of the total
variation in total quality of
Advanced cancer patients
with poor nutritional status
have a diminished quality



















Table 5 Nutritional status and quality of life in heterogeneous cancer population (Continued)
n= 1; Ovary: n = 1;Pancreas:





being (p = 0.000), functional
well-being (p = 0.000) and
social/spiritual well-being
(p = 0.040). PG-SGA score is
able to explain 36.9%,






quality of life in terminally




















n = 47; Breast: n = 63; lung:
n = 15; urinary: n = 31; Soft
tissue–skin–brain–CNS:
n = 7; Primary unknown:







Both PG-SGA & QoL are
used as continuous
variables
A small to medium
negative correlation was
found between PG-SGA
scores and life satisfaction
scores across all time
points.1. At baseline
(n = 218):r =−0.224,
p = 0.0012. At 6 months
(n = 196):r =−0.350,
p< 0.0013. At 12 months




















n = 105;Colorectal: n = 84;
Prostate: n = 67Females
(n = 449)Breast: n = 194;





(n = 622) & Weight
loss≥10% (n = 261)
(a) Mean Global QoL
score = 62.8 & 48.8
respectively for weight







Symptom scores were also




To improve QoL in patients
with cancer, a nutritional
intervention should be
implemented as soon as
cancer is diagnosed. The
nutritional therapy should
















cancerLung: n = 20; Breast:
n = 7;Gynecologic: n = 6;
Esophagus: n = 4; Others:
n = 13









Protein intake< 0.9 g/kg/d
&≥ 0.9 g/kg/d
1. Patients with hypo
albuminemia reported
more problems with
diarrhea (p = 0.05).2. Protein
intake below 0.9 g/kg was
associated to a poorer
perception on physical
functioning (p = 0.01), and
Nutrition is only one of the
factors that influence QoL
in cancer patients, but
nutritional evaluation of



















Table 5 Nutritional status and quality of life in heterogeneous cancer population (Continued)
Prealbumin9. Total
proteins
fatigue was close to




being fatigue (p = 0.06) the
closest relation.4. No other
nutritional parameters, like
percentage of weight loss,
were statistically related to
changes in QoL.
done, so as to offer better
treatment of symptoms















271Head and neckBase of
tongue: n = 11; Salivary
gland: n = 6; Tonsil: n = 4;
Nasopharynx: n = 11;
Oropharynx: n = 22; Larynx:
n = 33; Oesophagus: n = 14;
Stomach: n = 26;






≥ 10% weight loss &< 10%
weight loss over the
previous 6 months
Malnutrition was associated
with poorer function scales
and with some symptoms:
global QoL (P = 0.05),
physical (P = 0.01), role
(P = 0.02), cognitive
(P = 0.02), emotional
(P = 0.01) and social
(P = 0.01); anorexia
(P = 0.001), increased
fatigue (P = 0.03), dyspnea,
insomnia and diarrhea
(P = 0.04).
Although cancer stage was
the major determinant of
patients’ QoL globally,
there were some diagnoses
for which the impact of
nutritional deterioration
combined with deficiencies
in nutritional intake may be
more important than the












therapyto the head, neck,
rectal or abdominal area
PG-SGA EORTC-QLQ
C30
well-nourished (n = 39)
malnourished (n = 21)PG-




SGA score and global
QoLr =− 0.66, P< 0.001(B)
After 4 weeks of
radiotherapy –Correlation
between PG-SGA score and
global QoLr =− 0.61,
P< 0.001(C) Correlation




P< 0.00126% of the
variation of change in QoL
was explained by change
in PG-SGA score (P = 0.001).
A change in PGSGA score
of 9 resulted in a change
of 17 in the QoL score.





radiotherapy and can be
used to predict the














RiskOesophagus: n = 6;
Stomach: n = 5; Colorectal:
n = 46; Base of the tongue:
n = 3;Salivary gland: n = 1;








(A) EUROQOL –1. At
baseline:In HR patients,
baseline malnutrition was
associated with lower self
reported health status
(SRHS) (P = 0.002).2. At the
Malnutrition as assessed by
SGA was associated with a

















Table 5 Nutritional status and quality of life in heterogeneous cancer population (Continued)
n= 3; Oropharynx: n = 3;
Larynx: n = 11LR: Low
RiskProstate: n = 21;Breast:
n = 7;Lung : n = 5;Brain:
n = 4;Gallbladder: n = 6;





was associated with higher
SRHS (P = 0.03).(B) EORTC-
QLQ-C30 –(a) At baseline:
In HR patients, malnutrition
associated with worse
function scales: global QoL
(P = 0.05), physical
(P = 0.01), role (P = 0.02),
cognitive (P = 0.02),
emotional (P = 0.01) and
social (P = 0.01) as well as
symptoms: poor appetite
(P = 0.001) or increased
fatigue (P = 0.03)(b) At the
end of Radiotherapy:All
associations with function
scales were also present at
the end of treatment:
global QoL (P = 0.01),
physical (P = 0.02), role
(P = 0.02), cognitive
(P = 0.03), emotional
(P = 0.01) and social








In 1989 Prospective 104 biopsy-proven breast
cancer, ovarian cancer, or
small cell lung cancer.
Breast: n = 19;Ovarian:






1. GHQ2. QL Weight-losing group (−
weight loss): weight loss
of≥ 5% of habitual body
weight (n = 56) &Weight-
stable group (+ weight
loss): weight loss of< 5%
of habitual body weight
(n = 48)
General health, as assessed
by the GHQ score, was
rated significantly worse by








of life for the patients with
weight loss, and this result
was confirmed by a
significant group difference
on the modified QL.
Many ambulatory cancer
patients do not eat enough
to maintain weight and
that even a moderate
weight loss is associated
with psychological distress
















Figure 1 Flow-chart depicting MEDLINE search results.
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http://www.biomedcentral.com//11/1/27cross-sectional[20,21] and three were prospective
[22,23,27]. The sample size ranged from 48[22] to 1,555
[26] patients. The population under study had been diag-
nosed with cancer of the gastric/gastrointestinal region,
esophagus or cardia, colorectal region or pancreas. The
most commonly used nutritional assessment methods
were the percentage of weight loss, either alone[26,27,34]
or in combination with PG-SGA, phase angle measured
in terms of BIA or Fat Free Mass Index (FFMI) and
hand-grip dynamometry.[22] One study assessed nutri-
tional status in terms of postoperative weight loss mea-
sured by the difference in BMI.[23] Another study used
several different assessment measures including serum
albumin, prealbumin, serum transferrin, phase angle by
BIA and SGA.[24] The studies also employed various
tools to assess the patients’ QoL. The most commonly
used was the EORTC-QLQ-C30, either exclusively
[22,24,26,34] or together with other tools like EuroQol
EQ-5D[27] or together with an esophageal cancer spe-
cific module EORTC OES-18.[23] Weight loss was the
primary criterion for segregation of the study population
into groups for comparison. The studies used a variety of
criteria to divide the patients into groups, including well-
nourished vs. malnourished individuals[24], weight-stable
vs. weight-losing patients[27], and patients with and
without weight loss.[26] One study compared patient
groups based on a BMI decline of≥ 20% and< 20%.[23]
Another study segregated its population based on several
parameters that included> 10% weight loss in the previ-
ous six months or> 5% weight loss in the last month
and< 10% weight loss in the previous six months or< 5% weight loss in the last month, or as well-nourished,
moderately malnourished and severely malnourished (in
terms of PG-SGA scores), or grip strength below 85% &
above 85% (based on gand-grip dynamometry).[22] All 8
studies concluded that better nutritional status was posi-
tively associated with better QoL in the study patients.
Nutritional status and QoL in lung cancer
Table 3 describes the lone prospective study that
assessed the association between nutritional status and
QoL in 106 stage III and IV patients who had been diag-
nosed with inoperable non-small cell lung cancer
(NSCLC). The patients’ nutritional status was assessed in
terms of weight loss while QoL was assessed using
EORTC-QLQ-C30. The sample population was subdi-
vided into two groups: weight-stable and weight-losing
based on whether they had lost< 5% or> 5% weight.
The weight-stable patients reported better global QoL
and less fatigue and pain than the weight-losing group.
[28]
Nutritional status and QoL in gynecological cancer
Table 4 describes the lone prospective study that
assessed the association between nutritional status and
QoL in 157 gynecological cancer patients who required
surgery for a pelvic mass or who had a positive endomet-
rial biopsy. Nutritional status was assessed in terms of
BMI (used as a continuous variable) while QoL was
assessed using the SF-36 and FACT-G questionnaires.
More than 70% of the patients were either overweight or
obese. The study showed that higher BMI was negatively
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ate analyses.[29]
Nutritional status and QoL in heterogeneous cancer patient
populations
Table 5 describes the relationship between nutritional
status and QoL in heterogeneous cancer patient popula-
tions. Of a total of 10 studies listed in this table, one was
a transverse observational longitudinal study[31], three
were prospective longitudinal[2,3,7], one was descriptive
cross-sectional[6] and two were prospective cross-sec-
tional.[30,32] The remaining three studies were prospect-
ive.[5,10,33] The sample size ranged from 50[6] to 883
patients.[31] The population studied included patients
with solid or hematologic tumor disease; evolving cancer
at different management stages; non-terminal cancer
patients; ambulatory patients with head and neck,
esophageal, stomach and colorectal cancer; ambulatory
patients who were receiving radiation therapy to the
head, neck, rectal or abdominal area; patients with
tumors of the head and neck, gastrointestinal tract
(high-risk: HR), prostate, breast, lung, brain, gallbladder
or uterus (low-risk: LR); or biopsy-proven breast, ovar-
ian, or small cell lung cancer. The patients’ nutritional
status was most commonly assessed with the SGA, either
singly [7] or in combination with phase angle determined
by BIA[10] or in the form of PG-SGA scores.[2,3,5]
Three studies used weight loss as the nutritional assess-
ment tool[31-33] while another study assessed nutri-
tional status using multiple parameters, including BMI,
percentage of usual weight, ideal weight percentage of
ideal weight, percentage of weight loss, triceps skinfold
thickness, mid-upper arm circumference, serum albu-
min, prealbumin, total proteins and total cholesterol.[6]
The principal tool used for the measurement of QoL was
EORTC-QLQ-C30, either alone[2,5,6,31,32] or in com-
bination with EuroQoL.[7] The remaining three studies
used different QoL tools, including the Life Satisfaction
Scale[3], Hospice Quality of Life Index (HQLI)[5], and
the General Health Questionnaire (GHQ) together with
the Quality of Life Index (QL).[33] Two studies classified
their sample population into three distinct categories:
well nourished, moderately malnourished and severely
malnourished on the basis of SGA/PG-SGA scores.[5,7]
One study used PG-SGA scores as a continuous variable
[3] while another study treated PG-SGA scores as a con-
tinuous variable despite having categorized its patients as
being well nourished and malnourished.[2] Three studies
divided their sample into two categories each based on
percentage of weight loss using the cut-off criteria of
10% (i.e. < 10% &> 10% weight loss)[10,32] and 5% [i.e.
≥ 5% (weight-losing or –weight loss) and< 5% (weight-
stable or +weight loss)][33] respectively. Another study
grouped its sample population based on the quantity ofprotein intake (< 0.9 g/kg/d &≥ 0.9 g/kg/d).[6] One
study used two criteria to categorize its sample popula-
tion: SGA levels and BIA. The three groups included well
nourished, moderately malnourished and severely mal-
nourished based on SGA. Patients were also categorized
in two groups: below and above the fifth percentile of
the phase angle as measured by BIA.[10] Of the 10 stud-
ies, one showed that nutritional status was significantly
associated with QoL only for high-risk patients. This was
true when both EuroQoL and EORTC-QLQ-C30 were
used as tools for measurement of QoL.[7] Another study
concluded that nutritional status was not significantly
associated with QoL.[6] The remaining 8 studies showed
a positive correlation between nutritional status and QoL
[2,3,5,10,31-34].
Conclusion
Patient QoL is an extremely important outcome measure
for cancer patients. How patients feel, physically and
emotionally, while they are fighting cancer can have an
enormous effect on their ability to carry out normal daily
functions as well as on their interpersonal relationships
and their ability to work.
Cancer and its treatment affects the nutritional status
of patients by altering their metabolic function and redu-
cing their food intake.[5,6] Research has proven that
malnutrition is a predictor of morbidity in advanced can-
cer; therefore, malnutrition is also likely to assume a sig-
nificant role in patients’ QoL.[24] The present study
aimed to systematically review the relationship between
nutritional status and QoL in cancer patients. A total of
26 original studies were included in this review. Of the
26 studies, 6 investigated the correlation in head and
neck cancer patients, 8 in gastrointestinal cancer
patients, 1 in lung cancer patients, 1 in gynecologic can-
cer patients and 10 in heterogeneous cancer populations.
Better nutritional status was associated with better
QoL in all 6 studies of head and neck cancer patients
with each study identifying different reasons for the cor-
relation. One study reported that weight loss in some
patients was related to loss of speech and swallowing
capabilities, which may have affected patients’ ability to
take food by mouth.[17] Another study concluded that
weight loss of more than 10% had significant impact on
QoL scores at time of diagnosis and that it seemed to
significantly worsen global QoL, fatigue and pain. The
same study advised that patient weight loss should be
limited as much as possible starting at diagnosis and
continuing until six months after treatment.[18] Another
study showed that patients in the ≥10% weight-loss
group reported extreme problems (>80 points) with dry
mouth and sticky saliva at 3 months, 1 year and 3 years
after diagnosis. This effect was attributed, on the basis of
previous studies, to the fact that this patient population
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smokers/ex-smokers, a higher percentage of patients
with stage III to IV disease (95% vs 50%), a higher per-
centage of patients with pharyngeal cancer, and more
patients who received chemotherapy.[19] In summary,
these 8 studies indicate that poor nutritional status, mea-
sured primarily using weight loss, was a strong predictor
of patient QoL, measured primarily through EORTC
QLQ-C30, in head and neck cancer patients.
All 8 studies that explored the association between nu-
tritional status and QoL in gastrointestinal cancer
patients concluded that better nutritional status was
associated with better QoL. One study theorized that an
inflammatory response may contribute to weight loss in
advanced gastrointestinal cancer patients by increasing
energy expenditure and the turnover of specific amino
acids, which reprioritizes the body’s protein metabolism
away from peripheral tissues and toward the liver. This
process appears to contribute to the preferential loss of
protein (in particular, skeletal muscle) in such patients.
This in turn may be a cause of appetite loss and lowered
QoL in gastrointestinal cancer patients.[27]
The lone study that reported a significant relationship
between nutritional status and QoL in lung cancer
patients speculated that the relationship between pain
and more than 5% prior weight loss may simply be a re-
sult of more advanced disease, as there were a greater
number of weight loss patients in this group who had
been diagnosed with stage IV disease.[28] The lone study
that explored the association between nutritional status
and QoL in gynecological cancer patients indicated that
nutritional status (in terms of BMI) was significantly
associated with QoL.[29] More than 70% of the patients
were either overweight or obese suggesting that obesity
is another form of malnutrition that is often overlooked
in clinical settings, and can have a negative impact on
patient QoL.
Of the 10 studies that investigated the relationship be-
tween nutritional status and QoL in a heterogeneous can-
cer population, eight concluded that nutritional status was
significantly associated with QoL, one found nutritional
status to be significantly associated with QoL only for
high-risk patients[7], and one found no association be-
tween the two.[6] Of the eight studies reporting significant
association, one reported that although an association be-
tween malnutrition and impaired QoL was observed in all
sub-groups of patients, it was not possible to identify
which was the cause and which was the consequence:
weight loss or QoL. The authors attributed this issue to
the study design (transversal study).[31] Another study
also inferred that it was not possible to conclude which
came first – insufficient food intake, decreased QoL or
weight loss – although the authors did establish that the
three variables were interdependent.[33].Overall, among the 26 studies reviewed in this article,
24 concluded that better nutritional status was associated
with better QoL, one study showed that better nutri-
tional status was associated with better QoL only in
high-risk patients, and one concluded that there was no
association between nutritional status and QoL.
The majority of the studies reviewed in this article
used weight loss (expressed as weight loss or uninten-
tional weight loss or percentage of weight loss) as the
tool for assessment of nutritional status, either exclu-
sively[18,19,26-28,31-33] or in combination with other
methods.[8,12,22] The results described by these papers
suggest that weight loss is a good prognosticator of QoL
irrespective of the type of cancer for a number of rea-
sons. One, weight loss is a common feature of advanced
cancer due to patient distress and loss of independence.
[27] Weight loss is a known cause of morbidity and mor-
tality in cancer patients that also decreases patient toler-
ance to both radiotherapy and chemotherapy.[19]
Weight loss as low as 5% can alter important, measur-
able physiological parameters such as immune response,
lung and cardiac function tests and autonomic autoregu-
lation.[26] More than 10% weight loss at diagnosis has a
great impact on QoL scores.[18] A total weight loss of ≥
20% significantly correlates with treatment interruption,
infections, early mortality, hospital re-admission rate
after treatment completion as well as survival.[8] Recent
work suggests that an inflammatory response might con-
tribute to the weight loss in advanced gastrointestinal
cancer patients by increasing energy expenditure and the
turnover of specific amino acids, which reprioritizes the
body’s protein metabolism away from peripheral tissues
and toward the liver. This process apparently contributes
to the preferential loss of protein (in particular, skeletal
muscle) in such patients. The reprioritization of metab-
olism may also impact patient appetite and, along with
it, the QoL of gastrointestinal cancer patients.[27] There
is evidence in the literature reviewed that the use of “per-
centage weight loss since the start of the illness” is a rela-
tively objective measure, although the patient’s usual or
“normal” weight is often only approximately known. On
the other hand, percentage weight loss does not appear
to account for the kinetics of weight loss, presence of
edemas, water retention and clinical-biological effects.
[31] On the contrary, SGA is the only malnutrition
screening tool recommended by the ASPEN board of
directors.[35] SGA is a simple, easy-to-apply and cost-ef-
fective method that has been validated for diverse groups
of patients. SGA is one of the better available assessment
methods, not only because it is patient centred and
incorporates clinical history and physical examination,
but also does not require laboratory testing or medical
imaging exams.[36,37] Reliable SGA grading, however,
depends on collection of correct history and physical
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the assessment. Nutrition assessment tools such as the
scored PG-SGA enable nutritional status to be assessed
quickly, nutrition impact symptoms identified and ap-
propriate nutrition support implemented. An advantage
of the PG-SGA as a nutrition assessment tool is that the
score can be used as an outcome measure in nutrition
intervention studies as it may be more sensitive to
changes in nutritional status than the global SGA rating.
[38] Also, by performing serial measurements, the
change in the PG-SGA score may be used to demon-
strate subtle changes in nutritional status.
The majority of the studies reviewed here used
EORTC-QLQ-C30 to assess patient QoL, either exclu-
sively[2,8,10,22,24,26,28,31,32] or in combination with
other QoL tools.[7,12,18,19,23,27] The EORTC QLQ-
C30 questionnaire is a validated instrument for assessing
QoL in patients with cancer.[31] It is usually completed
by self-assessment[12,27] and covers more items and
scales, identifies more domains and specific complaints,
and assesses cancer and radiotherapy specific symptoms,
and is, therefore, a more comprehensive and sensible
measure than some others.
Collectively, the studies reviewed in this article suffered
from certain limitations. Three studies involved small sam-
ple sizes, which made comparisons and statistical analyses
difficult.[5,17,24] Non-responders contributed toward bias
in one study[17], while another made no assessment of in-
ter-rater reliability of the users of SGA and BIA. These
studies minimized this bias by using only BIA-trained die-
ticians.[24] Two studies reported exclusion of patients
with physical, cognitive, language or emotional problems
that prevented them from completing the respective QoL
questionnaires.[2,5] Another study was a secondary ana-
lysis and was not designed as a nutrition trial. As a result,
some of the nutritional parameters included in the survey
were limited. Also, there was significant attrition between
T2 and T3 and, apparently, more stage IV patients were
lost to attrition. Thus, the prevalence of nutrition impact
symptoms in these patients may have been underreported.
[3] One study reported that its outcome data may have
been misclassified, but then ruled out the probability of
error on the grounds that 1) the analysis of self-reported
preoperative body weight compared with body weight
measured by surgical staff before operation showed good
validity and 2) that the questionnaires covering nutritional
issues had been previously validated.[23]
Like most other systematic reviews of the literature,
this review suffers from potential publication bias. In
general, this bias exists because studies that report posi-
tive associations are more likely to be published. There-
fore, it is possible that studies containing valuable data
may not have been published and have gone undetected.
Since we restricted this systematic review to studiespublished in English, it is possible that language bias
may have affected our conclusions. Finally, our review
simply focused on the relationship between nutritional
status and QoL in cancer, which does not by any means
imply causation. As a result, a logical next step would be
to systematically review the available literature, if any, to
investigate whether nutritional intervention can have a
favorable impact on QoL outcomes in cancer patients.
Despite these limitations, our review and analysis of the
extensive available literature demonstrates a strong asso-
ciation between nutritional status and QoL in cancer.
Also as a result of our review, we have identified new
avenues for further research in this area. One is to iden-
tify the best management practices for timing of nutri-
tional assessment and intervention in cancer patients as,
currently, there is no consensus on how to manage
patients based on any of the nutritional metrics reviewed
here. Nonetheless, this review of the literature provides a
strong rationale for devising such standards of practice
and testing their value in controlled clinical studies. All
clinical manifestations of malnutrition should be
included, as well as specific situations where a causative
relationship with QoL is apparent.
Our review of the current literature supports the hy-
pothesis that nutritional status is a strong predictor of
QoL in cancer patients. It also supports an approach to
cancer treatment that takes all aspects of the patient’s life
into account. Further, the current literature supports the
implementation of the ASPEN guidelines for oncology
patients, which include nutritional screening, assessment,
and intervention as appropriate. Correcting malnutrition
in cancer patients can have a significant positive impact on
their QoL.
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